HALLADAY BENJAMIN (Chief Financial Officer) received a stock award from ESPERION THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/16/2026ACC: 0001628280-26-018186
Officer· Chief Financial Officer
Since Nov 2022
+468.70K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
468.70K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+247.43K
Price / share
—
Trade value
—
% of position
52.4%
3/13/2026
472.60K→720.03K
Total
Net shares
+247.43K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/13/2026 | A · Award | +247.43K | — | — | 52.4% | 472.60K | 720.03K |
| Total | +247.43K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
221.27K shares
Shares
+221.27K
Strike price
2.44
Held after
221.27K
Exercisable
—
3/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock221.27K shares | 3/13/2026 | A · Award | +221.27K | 2.44 | — | 221.27K |